ACHE and Alzheimer disease: In view of the decades of failures of other disease-modifying strategies and the critical need for effective treatments, AChE inhibitors offer an unparalleled opportunity for delaying the onset, slowing the disease, reducing disability and preserving the autonomy of patients at risk for AD.